A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 6, 2006, Pages 599-606

  Ettmayer, Peter ^b   Mayer, Peter ^b   Kalthoff, Frank ^b   Neruda, Wolfgang ^b   Harrer, Nathalie ^b   Hartmann, Gabriella ^b   Epstein, Michelle M ^b   Brinkmann, Volker ^b   Heusser, Christoph ^b   Woisetschläger, Maximilian ^a  

^a Novartis Institutes for Biomedical Research Vienna   (Austria)

^b NONE

Author keywords

Asthma; Immunobiology; Pharmacology

Indexed keywords

4 (3 CHLOROPHENYL)PYRIMIDIN 2 YL(4 TRIFLUOROMETHYLPHENYL)AMINE; CD86 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERLEUKIN 6; UNCLASSIFIED DRUG; VAF 347;

ARTICLE; ASTHMA; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD86; B-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; PYRIMIDINES; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS;

EID: 33644834346     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200503-468OC     Document Type: Article

References (41)

1. Corrigan C. Mechanisms of intrinsic asthma. Curr Opin Allergy Clin Immunol 2004;4:53-56.
2. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002;53:477-498.
3. Vercelli D. Immunoglobulin E and its regulators. Curr Opin Allergy Clin Immunol 2001;1:61-65.
4. Romagnani S. T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol 2001;1:73-78.
5. Vermaelen KY, Pauwels RA. Pulmonary dendritic cells. J Respir Crit Care Med 2005;172:530-551.
6. Chen L. Co-inhibitory molecules of the B7 CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-347.
7. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003;4:616-623.
8. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG. Ia-positive dendritic cells form a tightly network within the human airway epithelium. Clin Exp Allergy 1989;19:597-601.
9. Lambrecht BN, Hamad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003;3:994-1003.
10. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993;177:397-407.
11. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
12. Xia WJ, Pinto CE, Kradin RL. The antigen-presenting activities of Ia(+) positive dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 1995;181:1275-1283.
13. Graffi SJ, Dekan G, Stingl G, Epstein MM. Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 2002;103:176-184.
14. Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001;56:823-826.
15. Upham JW, Denburg JA, O'Byrne PM. Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 2002;32:818-823.
16. high) dendritic cells in human nasal allergy. J Immunol 2000;165:4062-4068.
17. Kerschenlohr K, Decard S, Przybilla B, Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 2003;111:869-874.
18. Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends Immunol 2002;23:31-39.
19. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev 2003;3:721-732.
20. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through Blys and APRIL. Nat Immunol 2002;3:822-829.
21. Zurawski G, de Vries J. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
22. +) B-cells to secrete IgG1 and IgG3. J Exp Med 1994;179:757-762.
23. Malisan F, Briere F, Bridon JM, Harindranath N, Mills FC, Max EE, Banchereau J, Martinez-Valdez H. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 1996;183:937-947.
24. + T cell-mediated suppression by dendritic cells. Science 2003;299:1033-1036.
25. Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent. 2. Regulation of human IgE response. Jpn J Pharmacol 1993;61:31-39.
26. Zhao GD, Yokoyama A, Kohno N, Sakai K, Hamada H, Hiwada K. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol 1999;121:116-122.
27. Kurokawa M, Kawazu K, Asano K, Fumio K, Mita A, Adachi M. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Mediators Inflamm 2001;10:333-337.
28. Kitamura D, Roes J, Kuhn R, Rajewsky KA. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991;350:423-426.
29. Hamelmann E, Tadeda K, Oshida A, Gelfand EW. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness: a murine model. Allergy 1999;54:297-305.
30. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992;175:671-682.
31. Woisetschläger M, Stütz AM, Ettmayer P. Prevention of immunoglobulin E production as a therapeutic target. Drug News Perspect 2002;15:78-84.
32. Djukanovic R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004;170:583-593.
33. Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, Isono K, Nagai A. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomized study. Lancet 2000;356:273-278.
34. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-718.
35. Ranger AM, Das MP, Kuchroo VK, Glimcher LH. B7-2 is essential for the development of IL-4-producing T-cells. Int Immunol 1996;8:1549-1560.
36. Brown JA, Titus RG, Nabavi N, Glimcher LH.Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis 1996;174:1303-1308.
37. Haczku A, Takeda K, Redai I, Hamelmann E, Cieslewicz G, Joetham A, Loader J, Lee JJ, Irvin C, Gelfand EW. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1999;159:1638-1643.
38. Harris N, Peach R, Naemura J, Linsley P, Le Gros G, Ronchese F. CD80 costimulation is essential for the induction of airway eosinophilia. J Exp Med 1997;185:177-182.
39. Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 2000;105:1063-1070.
40. Park HJ, Choi YS, Lee CE. Identification and activation mechanism of the interleukin-4-induced nuclear factor binding to the CD23(b) promoter in human B lymphocytes. Mol Cells 1997;7:755-761.
41. Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, Yoshie O. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004;78:1665-1674.